Creative Proteomics Launches Revolutionary DARTS Assay Service for Enhanced Drug Target Discovery

Creative Proteomics, a renowned Molecular Interaction CRO, is pleased to unveil its groundbreaking DARTS Assay Service, a pioneering technique reshaping the landscape of drug target identification. With a focus on delivering top-tier analytical services to the pharmaceutical industry and academic/nonprofit researchers, the patented DARTS technology offered by Creative Proteomics provides unparalleled insights into the binding of small molecule drugs to their target proteins.
 
The DARTS Assay Service at Creative Proteomics is built upon the patented Drug Affinity Responsive Target Stability (DARTS) technology, which leverages the reduced sensitivity of target proteins to protease degradation induced by small molecule drug binding. This innovative approach enables the company to conduct drug screening and target identification without the need for chemical modifications of compounds, offering a streamlined and efficient solution for its clients.
 
"Our DARTS Assay Service represents a paradigm shift in the field of drug target identification," said the senior scientist at Creative Proteomics. "By harnessing the latest proteomics and mass spectrometry technologies, we deliver comprehensive and accurate results to our clients, empowering them to make informed decisions in their drug discovery endeavors."
 
The DARTS experiments performed by Creative Proteomics utilize specific strategies to detect enzymatic digestion effects, including techniques such as SDS-PAGE, gum staining, two-dimensional polyacrylamide gel electrophoresis (2D-PAGE), and mass spectrometry (LC-MS/MS). These methods allow the company to compare differences in enzymatic digestion between treated and control groups, facilitating the discovery of potential drug targets for further investigation.
 
The DARTS Assay Service boasts a range of advantages, including unbiased proteome-wide drug target identification, specific protein target binding tests, and drug screening for "undruggable" therapeutic targets. Creative Proteomics' commitment to providing flexible, cost-effective, and time-saving target identification services is further enhanced by its sophisticated bioinformatics analysis, ensuring a thorough interpretation of the results.
 
To showcase the impact of the DARTS Assay Service, Creative Proteomics has developed a workflow that illustrates the process and highlights the key steps involved. This visual representation serves as a testament to the efficiency and effectiveness of the company's approach, guiding clients through the journey of drug target discovery with clarity and precision.
 
For more information about the DARTS Assay Service and other specialized analytical services offered by Creative Proteomics, please visit the company's website at https://www.creative-proteomics.com/
 
About Creative Proteomics
Creative Proteomics is a global leader in the field of proteomic services, with a reputation for its advanced methodologies, tailored solutions, and commitment to the highest level of quality and scientific integrity. Backed by a highly experienced scientific team, it offers comprehensive services dedicated to supporting researchers in the field of proteomics, metabolomics, and other life science research endeavors, thereby resulting in satisfying and reliable outcomes.
 
Contact
Address: Shirley, NY 11967, USA
Email: contact@creative-proteomics.com